Cargando…

Current status of rivaroxaban in elderly patients with pulmonary embolism (Review)

Acute pulmonary embolism (PE) occurs with a high incidence rate in elderly patients, demonstrating complex clinical manifestations, as well as a difficult anticoagulant treatment strategy. Currently, there is limited understanding of the selection criteria for anticoagulant treatment in elderly pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Zi-Kai, Cao, Hongyan, Wu, Haidi, Wei, Qi, Tang, Minglong, Yang, Shuo, Liu, Yang, Qin, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086161/ https://www.ncbi.nlm.nih.gov/pubmed/32256765 http://dx.doi.org/10.3892/etm.2020.8559

Ejemplares similares

Rivaroxaban treatment for young patients with pulmonary embolism (Review)
por: Wu, Haidi, et al.
Publicado: (2020)

Efficacy of low-dose rivaroxaban in an 88-year-old female with pulmonary embolism: A case report
por: Zhou, Huanyu, et al.
Publicado: (2019)

Routine coagulation test abnormalities caused by rivaroxaban: A case report
por: Song, Zikai, et al.
Publicado: (2018)

Nephrotic syndrome with acute pulmonary embolism in young adults: Two case reports
por: Song, Zikai, et al.
Publicado: (2018)

Association Between D-Dimer Level and In-Hospital Death of Pulmonary Embolism Patients
por: Song, Zi-Kai, et al.
Publicado: (2020)

Successful treatment of amniotic fluid embolism complicated by disseminated intravascular coagulation with rivaroxaban: A case report
por: Wu, Hai-Di, et al.
Publicado: (2020)

Rivaroxaban for the Treatment of Pulmonary Embolism
por: Vanassche, Thomas, et al.
Publicado: (2013)

Efficacy of rivaroxaban for pulmonary embolism
por: Jia, Juan, et al.
Publicado: (2019)

Considerations for routine coagulation monitoring with rivaroxaban: A case report and review of the literature
por: Wu, Hai-Di, et al.
Publicado: (2019)

Syncope as the initial presentation of pulmonary embolism in a young adult with testicular tumor: A case report and literature review
por: Song, Zikai, et al.
Publicado: (2018)

Massive Spontaneous Haemothorax after Rivaroxaban Therapy for Acute Pulmonary Embolism
por: Yan, Denise Tan, et al.
Publicado: (2019)

Effect of Rivaroxaban on Fibrinolytic Therapy in Massive Pulmonary Embolism: Two Cases
por: Kim, Hye-Jin, et al.
Publicado: (2014)

The Use of Rivaroxaban for Unprovoked Pulmonary Embolism in the Setting of Antithrombin Deficiency
por: Gryn, Oscar J, et al.
Publicado: (2020)

Sequential Therapy of Nadroparin and Rivaroxaban in the Initial Treatment of Patients With Acute Pulmonary Embolism
por: Xiong, Wei, et al.
Publicado: (2022)

Current Clinical Management Status of Pulmonary Embolism in China
por: Gong, Juan-Ni, et al.
Publicado: (2017)

Use of rivaroxaban in an elderly patient with intermediate-low early mortality risk due to pulmonary embolism: a case report
por: Menichetti, Maurizio, et al.
Publicado: (2015)

Rivaroxaban Monotherapy in Patients with Pulmonary Embolism: Off-Label vs. Labeled Therapy
por: Di Micco, Pierpaolo, et al.
Publicado: (2022)

Combination of D-dimer and simplified pulmonary embolism severity index to improve prediction of hospital death in patients with acute pulmonary embolism
por: Wu, Hai-Di, et al.
Publicado: (2020)

Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
por: Song, Yijun, et al.
Publicado: (2023)

Pulmonary embolism and deep vein thrombosis in eosinophilic granulomatosis with polyangiitis successfully treated with rivaroxaban
por: Naito, Tomoyuki, et al.
Publicado: (2018)

Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment
por: Di Tano, Giuseppe, et al.
Publicado: (2020)

Efficacy of rivaroxaban for the treatment of Chinese patients with acute pulmonary embolism: A retrospective study
por: Wang, Lei, et al.
Publicado: (2021)

Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed Thrombolysis
por: Groetzinger, Lara M., et al.
Publicado: (2018)

Treatment of Pulmonary Embolism With Rivaroxaban: Outcomes by Simplified Pulmonary Embolism Severity Index Score from a Post Hoc Analysis of the EINSTEIN PE Study
por: Fermann, Gregory J, et al.
Publicado: (2015)

Accidental Rivaroxaban Overdose in a Patient with Pulmonary Embolism: Some Lessons for Managing New Oral Anticoagulants
por: Sajkov, Dimitar, et al.
Publicado: (2015)

Efficacy and Safety of Rivaroxaban versus Warfarin for the Treatment of Acute Pulmonary Embolism: A Real-World Study
por: Huang, Yan, et al.
Publicado: (2020)

Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care
por: Peacock, W. Frank, et al.
Publicado: (2019)

Analysis of Effectiveness, Safety, and Bleeding Related to Rivaroxaban in Elderly Patients
por: Hou, Huimin, et al.
Publicado: (2020)

Syncope as the initial presentation of pulmonary embolism in two patients with hepatocellular carcinoma: Two case reports and literature review
por: Deng, Dayong, et al.
Publicado: (2021)

SUSTAINED VENTRICULAR TACHYCARDIA AS AN INITIAL PRESENTATION OF COVID-19 RELATED PULMONARY EMBOLISM DESPITE PREVIOUS RIVAROXABAN THERAPY
por: Mendoza, Juan Alan Fuentes, et al.
Publicado: (2022)

Management of acute pulmonary embolism with sequential hybrid therapy of surgical thrombectomy and rivaroxaban intensive therapy: a case report
por: Migita, Shohei, et al.
Publicado: (2023)

Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies
por: Wang, Yuqi, et al.
Publicado: (2013)

Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban
por: Liu, Xiao-Qin, et al.
Publicado: (2023)

Relative risk of pulmonary embolism in the very elderly compared with the elderly
por: Yayan, Josef
Publicado: (2013)

Current Management of Acute Pulmonary Embolism
por: Martinez Licha, Carlos R., et al.
Publicado: (2019)

Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism
por: Stöhr, Robert, et al.
Publicado: (2022)

Length of Stay Comparison between Rivaroxaban and Warfarin in the Treatment of Pulmonary Embolism: Results from a Real-World Observational Cohort Study
por: Roberts, Kirsten M., et al.
Publicado: (2015)

Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects
por: Ansell, Jack, et al.
Publicado: (2021)

Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J’xactly) study
por: Okumura, Yasuo, et al.
Publicado: (2018)

Central Retinal Vein Occlusion After Discontinuation of Rivaroxaban Therapy in a Young Patient with COVID-19 Pulmonary Embolism: A Case Report
por: Płatkowska-Adamska, Bernadetta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o01op1ih5pc20fu2k319t49gjv